LONDON (IT BOLTWISE) – AstraZeneca recently published impressive financial figures. The pharmaceutical company was able to increase its sales to 15.19 billion US dollars, an increase of over 1.6 billion US dollars compared to the previous year. Analysts had expected lower sales, which underlines the positive surprise on the market.
Today’s daily deals at Amazon! ˗ˋˏ$ˎˊ˗
The British-Swedish pharmaceutical company AstraZeneca recently presented its latest financial figures, which show impressive growth. Revenue rose to $15.19 billion, a significant increase from last year’s $13.57 billion. This development is primarily due to the company’s strong drug pipeline, which continues to provide positive momentum.
Adjusted earnings per share increased 14 percent to $2.38. This metric, which excludes extraordinary and one-time items, exceeded the expectations of analysts surveyed by Visible Alpha, who on average expected core earnings per share of $2.31. This positive development underlines AstraZeneca’s efficiency and growth potential.
The forecast for the full year 2025 remains optimistic. AstraZeneca expects revenue growth in the high single-digit percentage range and core earnings per share growth in the low double-digit percentage range. These predictions reflect the company’s confidence in its future development, particularly given its strong pipeline and continued investments in research and development.
On the stock market, AstraZeneca shares reacted in London with a slight decline of 0.19 percent to GBP 124.26. This reaction could be due to profit-taking following the positive news. Nevertheless, the long-term outlook for the company remains promising as demand for innovative medicines remains high.
Order an Amazon credit card without an annual fee with a credit limit of 2,000 euros!
Bestseller No. 1 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 2 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 3 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 4 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 5 ᵃ⤻ᶻ “KI Gadgets”
Please send any additions and information to the editorial team by email to de-info[at]it-boltwise.de. Since we cannot rule out AI hallucinations, which rarely occur with AI-generated news and content, we ask you to contact us via email and inform us in the event of false statements or misinformation. Please don’t forget to include the article headline in the email: “AstraZeneca records sales growth thanks to strong drug pipeline”.